OMER · Omeros Corp · Financials
$18.47
-0.57 (-2.99%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.45B
Shares
72.39M
Volume · Oct 1
1.24M
Avg daily vol (3M)
1.77M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$73.81M
-34%
FY2020
Net Income
-$3.35M
+97.9%
FY2025
Gross Margin
98.78%
-0.4pp
FY2020
Operating Margin
-212.59%
-82pp
FY2020
Diluted EPS
-$0.05
+98.1%
FY2025
Operating Cash Flow
-$116.09M
+22%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $73.81M | $111.81M | $29.87M | $64.83M | $41.62M | $13.51M | $539K | $1.6M | $6.02M | $4.52M | $2.11M | $1.44M | |
| — | — | — | — | — | — | $902K | $865K | $512K | $1.08M | $1.41M | $1.04M | $0 | $0 | — | — | — | — | |
| — | — | — | — | — | — | $72.91M | $110.94M | $29.36M | $63.75M | $40.21M | $12.47M | $539K | $1.6M | — | — | — | — | |
| — | — | — | — | — | — | 98.78% | 99.23% | 98.29% | 98.34% | 96.61% | 92.29% | 100% | 100% | — | — | — | — | |
| $62.6M | $81.3M | $119.52M | $114.87M | $112.72M | $118.78M | $107.61M | $106.32M | $89.86M | $55.6M | $50.7M | $48.38M | $47.95M | $36.3M | $31.92M | $23.72M | $23.47M | $16.93M | |
| $48.15M | — | — | — | $50.67M | $54.84M | $49.31M | $39.71M | $51.72M | $52.04M | $43.78M | $35.33M | $22.6M | $15.82M | $10.99M | $8.22M | $8.75M | $5.27M | |
| $47.26M | $41.5M | $47.43M | $49.66M | $50.67M | $54.84M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $907K | $964K | $950K | $920K | $952K | $1.39M | $1.62M | $1.79M | $962K | $551K | $300K | $209K | $317K | $302K | $320K | $435K | $472K | $451K | |
| $153.83M | — | — | — | — | — | — | — | $142.09M | $108.72M | $95.89M | $84.75M | $70.55M | $52.12M | $42.91M | $31.93M | $32.21M | $22.2M | |
| $111.24M | $122.8M | $166.95M | $164.53M | $163.39M | $173.62M | $156.92M | $146.04M | $142.09M | $108.72M | — | — | — | — | — | — | — | — | |
| -$72.82M | -$122.8M | -$166.95M | -$164.53M | -$163.39M | -$173.62M | -$156.92M | -$146.04M | -$112.22M | -$43.9M | -$54.28M | -$71.24M | -$70.01M | -$50.52M | -$36.89M | -$27.41M | -$30.11M | -$20.76M | |
| — | — | — | — | — | — | -212.59% | -130.62% | -375.73% | -67.71% | -130.42% | -527.34% | -12988.5% | -3157.25% | -612.5% | -605.88% | -1430.21% | -1437.53% | |
| -$71.91M | -$121.83M | -$166M | -$163.61M | -$162.44M | -$172.23M | -$155.3M | -$144.25M | -$111.26M | -$43.34M | -$53.98M | -$71.03M | -$69.69M | -$50.21M | -$36.57M | -$26.98M | -$29.63M | -$20.31M | |
| $8.85M | -$960K | $24.68M | $30.84M | $22.7M | $19.67M | $26.75M | $22.66M | $16.25M | $11.03M | $7.82M | $3.57M | $3.47M | $2.37M | $1.73M | $1.88M | $1.54M | $2.2M | |
| — | $2.3M | $8.4M | $14.7M | $2.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $2.15M | — | — | — | — | $1.74M | $654K | $1.55M | $1.78M | $1.44M | $945K | — | -$207K | $574K | $130K | $697K | $2.52M | $1.66M | |
| — | -$2.8M | -$180.32M | -$174.92M | -$182.03M | -$191.55M | -$196.39M | -$167.14M | -$139.69M | -$53.48M | -$66.75M | — | — | — | — | — | — | — | |
| — | $2.01M | $2.31M | $0 | $0 | $0 | -$23.26M | -$19.77M | -$12.93M | $0 | $0 | — | — | — | — | — | — | — | |
| $124.83M | -$3.35M | -$156.82M | -$117.81M | $47.42M | $194.24M | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.25M | -$21.09M | |
| — | — | — | — | — | — | -187.04% | -75.57% | -424.39% | -82.5% | -160.38% | -555.9% | -13668.46% | -2487.25% | -638.39% | -630.99% | -1389.6% | -1460.46% | |
| -$123.66M | — | — | — | — | — | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.29M | -$20.95M | |
| USD/shares | $1.92 | -$0.05 | -$2.70 | -$1.88 | $0.76 | $3.12 | -$2.41 | -$1.71 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | $1.73 | -$0.05 | -$2.70 | -$1.88 | $0.76 | $3.12 | -$2.41 | -$1.71 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 63.51M | 58.17M | 62.74M | 62.74M | 62.34M | 57.18M | 49.52M | 48.58M | 45.54M | 40.45M | 37.56M | 33.23M | 28.56M | 24.16M | 22.21M | 21.42M | — |
| shares | — | — | — | — | 62.74M | 62.34M | 57.18M | 49.52M | 48.58M | 45.54M | 40.45M | 37.56M | 33.23M | 28.56M | 24.16M | 22.21M | 21.42M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: $16.51M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 7.46×
EV/EBIT
—
Peer median 13.48×
P/E (TTM)
—
Peer median 18.23×
Peer medians compare against the 265 similar-size Biotechnology companies (of 532 listed).